tm logo
X
Live/Pending
NOTICE OF ALLOWANCE - ISSUED

issued

on 04 Jun 2024

Last Applicant/ Owned by

7141 Regal Lane

Knoxville

TN

37918

Serial Number

97792220 filed on 13th Feb 2023

Registration Number

N/A

Correspondent Address

Wade R. Orr Luedeka Neely, P.C.

P.O. Box 1871

Knoxville, TN 37901

UNITED STATES

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

X

Chemical analysis; Chemical analysis services; Chemical research and analysis; Chemical, biochemical, biological and bacteriological research and analysis; Clinical research in the field of Lipid Nanoparticles, Liposomes, and Hybrid Nanoparticles; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services; Produ Read More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Chemical analysis; Chemical analysis services; Chemical research and analysis; Chemical, biochemical, biological and bacteriological research and analysis; Clinical research in the field of Lipid Nanoparticles, Liposomes, and Hybrid Nanoparticles; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services; Product development; Product development and engineering services for others; Product development consultation; Product development consulting in the field of Lipid Nanoparticles (LNPs) and Liposome Samples. LNP and Liposome Formulation, Manufacturing, and Analytical Services; Product development for others; Product research and development; Basic and clinical research in the field of respiratory science and medicine; Consulting services for others in the field of design, planning, and implementation project management of Lipid Nanoparticles, Liposomes, and Hybrid Nanoparticles; Consulting services in the field of product design and development; Design and testing for new product development; Executing of chemical analyses; Medical and scientific research, namely, conducting clinical trials for others; Performance of chemical analyses; Providing a web site featuring technology enabling physicians to access resources in clinical medicine; Providing a website featuring educational information in the field of clinical research; Providing information on clinical studies via an interactive website; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing reagent sample testing and diagnostic services for others for scientific research purposes; Scientific research in the nature of conducting clinical trials for others; Scientific research in the nature of conducting clinical trials for others in the field of Lipid Nanoparticles, Liposomes, and Hybrid Nanoparticles; Testing, analysis and evaluation of leaf and petiole samples; Working on and evaluation of chemical analyses


First Use Date in General

11th 000101

First Use Date in Commerce

11th 000101

Mark Details


Serial Number

No 97792220

Mark Type

No Service Mark

Attorney Docket Number

No 77248.M1

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

26.01.21 -

Circles that are totally or partially shaded

26.01.29 -

Helixes

27.01.04 -

Letters or numerals, including punctuation, forming representations of objects, parts of objects, or maps

Description of Design Search

The mark consists of a stylized letter "X" and design. The design consists of a circle and within the circle is a letter "X" formed by a stylized DNA helix symbol.

Legal History


Show more

Status DateAction Taken
04th Jun 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
02th Apr 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02th Apr 2024PUBLISHED FOR OPPOSITION
13th Mar 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
24th Feb 2024APPROVED FOR PUB - PRINCIPAL REGISTER
24th Feb 2024TEAS/EMAIL CORRESPONDENCE ENTERED
24th Feb 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
12th Feb 2024TEAS/EMAIL CORRESPONDENCE ENTERED
12th Feb 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
12th Feb 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED